Baum Richard P - THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging (PET/CT) ENETS Center of Excellence, Zentralklinik Bad Berka

基本信息

浏览量：15

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 972 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Optimizing Theranostics Chatbots with Context-Augmented Large Language Models

Pia Koller, Christoph Clement, Albert van Eijk,Robert Seifert,Jingjing Zhang, George Prenosil, Mike M Sathekge,Ken Herrmann,Richard Baum, Wolfgang A Weber,Axel Rominger,Kuangyu Shi

Theranosticsno. 12 (2025): 5693-5704

引用0浏览0WOS引用

Extended Peptide Receptor Radionuclide Therapy: Evaluating Nephrotoxicity and Therapeutic Effectiveness in Neuroendocrine Tumor Patients Receiving More Than Four Treatment Cycles

Richard P. Baum,Xin Fan,Vivianne Jakobsson,Christiane Schuchardt,Xiaoyuan Chen,Fei Yu,Jingjing Zhang

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGno. 4 (2024): 1136-1146

引用0浏览0WOS引用

Impressive Response to TANDEM Peptide Receptor Radionuclide Therapy with 177Lu/225acdota-Lm3 Somatostatin Receptor Antagonist in a Patient with Therapy-Refractory, Rapidly Progressive Neuroendocrine Neoplasm of the Pancreas

Elisabetta Perrone,Kriti Ghai,Aleksandr Eismant,Mikkel Andreassen,Seppo W. Langer,Ulrich Knigge,Andreas Kjaer,Richard P. Baum

Diagnosticsno. 9 (2024): 907-907

引用0浏览0WOS引用

Review on the Increasing Role for PSMA-Based Radioligand Therapy in Prostate Cancer

Finn Edler von Eyben,Irene Virgolini,Richard Baum

crossref（2024）

引用0浏览0引用

Comparison of Dosimetry Results Obtained with Different Software Tools in First In-Human Use of 177Lutetium-Labelled HER2 Affibody in a Patient with Breast and Lung Cancer

R. Moretti, E. Perrone,A. Eismant, K. Ghai,L. Greifenstein, D. Benz-Zils,A. Capotosti,R. P. Baum

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2024): S806-S806

引用0浏览0引用

Peptide Targeted Radioligand Therapy (PTRT) Using Fibroblast Activation Protein (FAP) Labelled with 225actinium As Mono- or TANDEM-therapy: A Retrospective Analysis of Long-Term Safety and Survival in Patients with Progressive, End-Stage Malignancies

E. Perrone,A. Mishra,A. Eismant, K. Ghai,L. Greifenstein,R. P. Baum

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2024): S35-S35

引用0浏览0引用

Peptide Receptor Radiopeptide Therapy (PRRT) Using the 225Actinium-and 225actinium/177lutetiumlabelled (TANDEM) Somatostatin-Receptor (SSTR) Antagonist DOTA-LM3 in Patients with Neuroendocrine Neoplasms (NEN): A Retrospective Study Concerning Safety and Survival

E. Perrone,A. Mishra,A. Eismant, K. Ghai,L. Greifenstein,R. P. Baum

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2024): S125-S125

引用0浏览0引用

3BP-3940, a Highly Potent FAP-targeting Peptide for Theranostics - Production, Validation and First in Human Experience with Ga-68 and Lu-177

Lukas Greifenstein, Annika Gunkel,Aileen Hoehne,Frank Osterkamp,Christiane Smerling,Christian Landvogt, Corinna Mueller,Richard P. Baum

JOURNAL OF NUCLEAR MEDICINE (2024)

引用5浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn